Form 4: P&G CEO-Grooming Sells Shares After Option Exercise
Insider Transaction Report
Gary A. Coombe, CEO Grooming at Procter & Gamble, exercised stock options and subsequently sold an equal number of common shares under a 10b5-1 plan.
Summary
- Gary A. Coombe, CEO Grooming of Procter & Gamble Co. (PG), engaged in transactions on February 12, 2026.
- Exercised stock options to acquire 36,093 shares of common stock at an exercise price of $78.52 per share.
- Immediately sold 36,093 shares of common stock at a weighted average price of $162.3307 per share, with the price ranging from $162.33 to $162.35.
- The transactions were conducted under a Rule 10b5-1(c) plan, indicating they were pre-scheduled.
- Beneficial ownership of direct common stock after these transactions is 34,993.7893 shares.
- Indirect beneficial ownership includes 486.4342 shares held by a Retirement Plan Trustee and 1,295.35 shares through an International Stock Ownership Plan & Pension Plan (Switzerland).
- Acquired 63.6893 Restricted Stock Units (RSUs) as dividend equivalents, bringing total RSU beneficial ownership to 1,117.3663 units.
- Following the exercise, 36,093 stock options are reported as beneficially owned.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While a sale of shares by an insider can sometimes be seen negatively, the context of an option exercise and a 10b5-1 plan makes it a routine compensation event, reflecting the executive monetizing long-held equity.
Positives
- The CEO exercised stock options at a significantly lower price ($78.52) than the market sale price ($162.3307), indicating a substantial personal gain from the company's stock appreciation.
- The transactions were pre-planned under a Rule 10b5-1(c) plan, which helps mitigate concerns about insider trading and suggests a systematic approach to managing equity compensation.
Negatives
- The CEO sold a substantial number of shares (36,093), which, while common after option exercise, represents a reduction in direct personal exposure to the company's common stock.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, as it primarily reports historical insider transactions.
Industry Context
StockSavvy.ai notes that insider transactions, particularly those executed under Rule 10b5-1 plans, are common for executives managing their equity compensation and personal finances. While a sale of shares might sometimes raise questions, the pre-planned nature of these transactions typically indicates a systematic approach rather than a reaction to immediate company performance or outlook. This is a routine compensation-related event for a senior executive at a large consumer staples company like Procter & Gamble.
Comparison to Industry Standards
- This type of 'sell-to-cover' or 'exercise-and-sell' transaction is a standard practice for executives across various industries, including consumer staples giants like Unilever, Kimberly-Clark, and Colgate-Palmolive, where executives regularly monetize vested stock options or restricted stock units as part of their long-term incentive plans.
- The significant spread between the exercise price and sale price reflects the long-term appreciation of Procter & Gamble's stock, a common outcome for executives holding options for several years in stable, dividend-paying companies.
Related Party Transactions
- The transactions involve the exercise of stock options and subsequent sale of common stock by a company executive, which are considered related-party dealings as part of the executive's compensation plan with Procter & Gamble.
Stakeholder Impact
- Shareholders: The sale of shares by an executive could be perceived as a slight negative, but the pre-planned nature and the fact it follows an option exercise mitigate this. The executive still retains significant direct and indirect holdings.
- Employees: No direct impact.
- Customers/Suppliers/Creditors: No direct impact.
Key Dates
| Date | Description |
|---|---|
| 02/26/2021 | Stock option exercisable date |
| 11/17/2025 | Restricted Stock Units (RSUs) acquisition date (dividend equivalents) |
| 12/31/2025 | PST adjustment date for indirect common stock ownership |
| 02/12/2026 | Date of stock option exercise and common stock sale |
| 02/13/2026 | Signature date of reporting person's attorney-in-fact |
| 02/28/2028 | Stock option expiration date |
Recommendation
holdThis Form 4 filing details a routine insider transaction where an executive exercised stock options and sold shares under a pre-arranged 10b5-1 plan. Such transactions are common for executive compensation and do not typically signal a change in the company's fundamental outlook or warrant a change in investment thesis. The significant profit realized by the executive from the option exercise reflects past stock appreciation, which is generally positive. Therefore, a 'hold' recommendation is appropriate as this filing provides no new information to alter an existing investment stance.
Keywords
Procter & Gamble, PG, Insider Trading, Form 4, Stock Options, Share Sale, Executive Compensation, Rule 10b5-1, Gary A. Coombe, CEO Grooming
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.